Table 3.
Characteristics | Retained in care AOR (95 % CI) | Use of ART AOR (95 % CI) | Viral suppression AOR (95 % CI) |
---|---|---|---|
Mental illness | |||
No | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
Yes | 1.30 (0.63, 2.56) | 0.79 (0.49, 1.25) | 0.64 (0.46, 0.90) |
Age (years) | |||
18-29 | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
30-39 | 0.86 (0.41, 1.83) | 3.70 (1.65, 8.31) | 2.05 (1.01, 4.15) |
40-19 | 1.46 (0.64, 3.34) | 2.26 (1.24, 4.11) | 3.26 (1.98, 5.38) |
>49 | 1.93 (0.86, 4.35) | 3.79 (1.76, 8.16) | 4.06 (2.39, 6.90) |
Sex | |||
Male | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
Female | 1.32 (0.68, 2.58) | 0.45 (0.30, 0.67) | 0.56 (0.33, 0.80) |
Race/ethnicity | |||
White | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
Black | 0.97 (0.45, 2.13) | 0.90 (0.45, 1.77) | 0.45 (0.22, 0.93) |
Hispanic | 1.02 (0.27, 3.85) | 0.79 (0.29, 2.19) | 0.86 (0.39, 1.91) |
Other/unknown | 0.93 (0.24, 3.70) | 0.56 (0.18, 1.75) | 0.43 (0.14, 1.37) |
Insurance | |||
Private | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
Medicaid | 1.10 (0.53, 2.29) | 0.88 (0.44, 1.75) | 0.73 (0.40, 1.35) |
Medicare | 1.51 (0.51, 4.48) | 2.69 (0.69, 10.46) | 1.07 (0.57, 2.03) |
Ryan white/uninsured | 2.13 (0.52, 8.74) | 1.06 (0.38, 2.97) | 1.66 (0.62, 4.41) |
Other/unknown | 0.49 (0.22, 1.08) | 0.65 (0.24, 1.76) | 0.80 (0.32, 1.96) |
CD4 cell count | |||
<201 cell/mm3 | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
201-350 cell/mm3 | 1.08 (0.51, 2.29) | 0.41 (0.15, 1.07) | 3.37 (1.89, 6.02) |
351-500 cell/mm3 | 3.52 (1.23, 10.13) | 0.34 (0.14, 0.83) | 3.37 (1.95, 5.83) |
>500 cell/mm3 | 1.35 (0.59, 3.07) | 0.27 (0.11, 0.65) | 4.40 (2.47, 7.83) |
Unknown | 0.06 (0.02, 0.14) | 0.08 (0.03, 0.23) | 0.38 (0.06, 2.31) |
Alcohol abuse | |||
No | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
Yes | 0.72 (0.28, 1.85) | 0.76 (0.40, 1.45) | 0.75 (0.44, 1.27) |
Injection drug use | |||
No | 1.00 (Ref) | 1.00 (Ref) | 1.00 (Ref) |
Yes | 1.28 (0.48, 3.46) | 0.73 (0.35, 1.54) | 0.95 (0.53, 1.69) |
Bold values indicate statistical significance (p < 0.05)
AOR adjusted odds ratio, ART antiretroviral therapy, CI confidence interval